Search research articles
Contact Us
Filters
Showing results (1-10 of 32) with videos related to
Page
of 4
Sort By:
Cancer Treatment and Research Communications
|
January 27, 2023
Niclosamide in prostate cancer: An inhibitor of AR-V7, a mitochondrial uncoupler, or more?
Minas Sakellakis
Chemotherapy
|
June 21, 2023
Why Metformin Should Not Be Used as an Oxidative Phosphorylation Inhibitor in Cancer Patients
Minas Sakellakis
The Prostate
|
May 10, 2022
Orphan receptors in prostate cancer
Minas Sakellakis
Molecular Diagnosis & Therapy
|
January 4, 2023
The Role οf Ion Channels in the Development and Progression of Prostate Cancer
Minas Sakellakis, Athanasios Chalkias
Cureus
|
April 4, 2023
Current Status of Tivozanib in the Treatment of Patients With Advanced Renal Cell Carcinoma
Minas Sakellakis, Roubini Zakopoulou
Medicine
|
July 22, 2022
Is the glucocorticoid receptor a key player in prostate cancer?: A literature review
Minas Sakellakis, Laura Jacqueline Flores
Current Urology
|
January 30, 2023
Androgen receptor signaling-mitochondrial DNA-oxidative phosphorylation: A critical triangle in early prostate cancer
Minas Sakellakis, Laura Jacqueline Flores
Experimental and Therapeutic Medicine
|
May 2, 2022
Patterns of indolence in prostate cancer (Review)
Minas Sakellakis, Laura Jacqueline Flores, Sumankalai Ramachandran
Iranian Red Crescent Medical Journal
|
June 4, 2016
Iris Metastasis in a Patient With Small Cell Lung Cancer: A Case Report
Minas Sakellakis, Stavros Peroukides, Gregoris Iconomou, et al.
Chemotherapy
|
May 23, 2015
β-Blocker Use and Risk of Recurrence in Patients with Early Breast Cancer
Minas Sakellakis, Anastasia Kostaki, Ioannis Starakis, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 32) with videos related to
Sort By:
Page
of 4
Cancer Treatment and Research Communications
|
January 27, 2023
Niclosamide in prostate cancer: An inhibitor of AR-V7, a mitochondrial uncoupler, or more?
Minas Sakellakis
Chemotherapy
|
June 21, 2023
Why Metformin Should Not Be Used as an Oxidative Phosphorylation Inhibitor in Cancer Patients
Minas Sakellakis
The Prostate
|
May 10, 2022
Orphan receptors in prostate cancer
Minas Sakellakis
Molecular Diagnosis & Therapy
|
January 4, 2023
The Role οf Ion Channels in the Development and Progression of Prostate Cancer
Minas Sakellakis, Athanasios Chalkias
Cureus
|
April 4, 2023
Current Status of Tivozanib in the Treatment of Patients With Advanced Renal Cell Carcinoma
Minas Sakellakis, Roubini Zakopoulou
Medicine
|
July 22, 2022
Is the glucocorticoid receptor a key player in prostate cancer?: A literature review
Minas Sakellakis, Laura Jacqueline Flores
Current Urology
|
January 30, 2023
Androgen receptor signaling-mitochondrial DNA-oxidative phosphorylation: A critical triangle in early prostate cancer
Minas Sakellakis, Laura Jacqueline Flores
Experimental and Therapeutic Medicine
|
May 2, 2022
Patterns of indolence in prostate cancer (Review)
Minas Sakellakis, Laura Jacqueline Flores, Sumankalai Ramachandran
Iranian Red Crescent Medical Journal
|
June 4, 2016
Iris Metastasis in a Patient With Small Cell Lung Cancer: A Case Report
Minas Sakellakis, Stavros Peroukides, Gregoris Iconomou, et al.
Chemotherapy
|
May 23, 2015
β-Blocker Use and Risk of Recurrence in Patients with Early Breast Cancer
Minas Sakellakis, Anastasia Kostaki, Ioannis Starakis, et al.
Page
of 4